This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This MLLT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 523-552 amino acids from the C-terminal region of human MLLT1.
anticorps MGC84026, anticorps MLLT1, anticorps ENL, anticorps LTG19, anticorps YEATS1, anticorps AA407901, anticorps BAM11, anticorps MLLT1, super elongation complex subunit, anticorps myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 L homeolog, anticorps myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1, anticorps Mllt1, anticorps MLLT1, anticorps mllt1.L, anticorps mllt1
Sujet
Chromosome band 11q23 is the site of translocations in myeloid and lymphoid acute leukemias, pediatric leukemias, and treatment-induced secondary acute myelogenous leukemia. The translocation breakpoints cluster in a restricted region of the HRX gene resulting in chimeric genes that encode an N-terminal portion of Hrx fused to various partner proteins. Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) is a nuclear protein with transcriptional transactivation properties that is fused to Hrx in t(11,19) leukemias. The minimal MLLT1 sequence required for transcription activation was narrowed to the C-terminal 90 amino acids.